Literature DB >> 23058034

Co-expression of multiple cytokines and their receptors in primary clear cell sarcoma of the pubic bone with features of a small round cell tumor.

S Nakayama1, T Yokote, K Iwaki, Y Hirata, T Akioka, T Miyoshi, A Takayama, U Nishiwaki, Y Masuda, M Tsuji, T Hanafusa.   

Abstract

We present the case of an 81-year-old man with primary clear cell sarcoma (CCS) of the pubic bone with an associated aggressive clinical course. The patient's laboratory tests showed marked leukocytosis, elevated levels of C-reactive protein and multiple cytokines, including interleukin-6 (IL-6) and granulocyte colony-stimulating factor (G-CSF). Histological examination showed monomorphic small cells predominantly arranged as a diffuse sheet with morphological features of a small round cell tumor (SRCT). Immunohistochemical staining indicated that the tumor cells were positive for HMB45, S100, Melan A, IL-6, IL-6 receptor, G-CSF, and G-CSF receptor and negative for cytokeratin (AE1/AE3) and epithelial membrane antigen. To the best of our knowledge, this is the first case report of aggressive primary CCS of the pubic bone with features of SRCT showing the production and co-expression of multiple cytokines and their receptors. Thus, we suggest that proliferation through an IL-6- and G-CSF-associated autocrine mechanism may play an important role in the aggressive clinical course and poor prognosis of some CCSs showing features of SRCT.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23058034     DOI: 10.1177/039463201202500330

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  1 in total

1.  Paraneoplastic granulocyte colony-stimulating factor secretion in soft tissue sarcoma mimicking myeloproliferative neoplasia: a case report.

Authors:  Christiane Dorn; Stefanie Bugl; Elke Malenke; Martin R Müller; Katja C Weisel; Ulrich Vogel; Marius Horger; Lothar Kanz; Hans-Georg Kopp
Journal:  BMC Res Notes       Date:  2014-05-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.